Develop a widely used immuno-surveillance technique that may help determine whether an individual's new coronary vaccine is effective and how long the resulting protective force lasts

January 7, 2021 // -- As the new crown vaccine becomes more available to the public, body immune surveillance will play an important role in determining whether the vaccine is effective for individuals and for how long, and scientists from the University of Alabama have developed a new technique that could be used for home antibody testing.
researcher Benjamin Larimer says the diagnostic technique we developed is an accurate and reliable way to help determine whether an individual can be protected against COVID-19, a technique that identifies neutral antibodies in the inoculator's body that block virally infected host cells, and new research suggests that the neutral antibody provides the body with the best protection against the virus, while the most widely used antibody detection methods do not specifically identify neutral antibodies.
these neutral antibodies can only be tested with a high level of accuracy by using complex and time-consuming laboratory tests, which are simply not available to the general population.
Photo Source: sagaciousnewsnetwork.com According to researchers, existing antibody testing methods can use a wide range of methods to locate antibodies, this antibody can adsorb smaller and different fragments of the virus, the current detection method may be other viruses (such as common cold virus) antibodies mistaken for COVID-19 infection produced antibodies, which in turn lead to false positive results.
In order to develop new testing techniques, researcher Larimer et al. began to break down the SARS-CoV-2 virus into small fragments to identify specific locations of the virus that antibodies could absorb;
Each vaccine is developed with the goal of allowing the body itself to produce antibodies as a first line of defense against the virus, and tests specifically designed to detect these antibodies can be used to measure the effectiveness of the new crown vaccine and help predict how long the protective effects of the vaccine will last.
the researchers speculate that the body's immunity to COVID-19 will not last forever, and that even after widespread vaccination of the new crown vaccine, immunization surveillance may last for years.
Clinical trials have shown that the COVID-19 vaccine can be very successful, but even 95 percent of its effectiveness leaves millions of Americans unsealed, and antibody testing may help determine the effectiveness of vaccinations and help clarify whether a person is protected against viral infections by vaccination.
to turn the new technology we've developed into a cheap and easy-to-use test that will provide the public with home immune surveillance,' said Larimer, a researcher at the university.
research foundation at the University of Alabama has filed a temporary patent application for the technology.
() Original source: Researchers develop technology to aid COVID-19 vaccine immunity monitoringby University of Alabama at BirminghamAs the COVID-19 vaccine bes free to the public, immunity monitoring will play an important role in determining if the vaccine is for an individual, and how long. Benjamin Larimer, Ph.D., researcher at the University of Alabama at Birmingham, has developed a technology with potential use as an in-home antibody test. Larimer's diagnostic test is an accurate and reliable method for determining whether individuals are protected against COVID-19. The technology identifies neutralizing antibodies—those that block the virus from infecting cells. Emerging research suggests neutralizing antibodies offer the best protection against the virus. The most widely used antibody tests today do not specifically identify neutralizing antibodies. Currently, these neutralizing antibodies can only be measured at a high level of accuracy using complicated and time-consuming laboratory tests not available to the general public......